Method for treating cancer patients with severe renal impairment
DCFirst Claim
Patent Images
1. A method for treating cancer which is one of gastrointestinal cancer, large bowel cancer and breast cancer, comprising:
- detecting a creatinine clearance of a patient; and
orally administering to the patient with a creatinine clearance of less than 30 mL/min a combination drug comprising α
,α
,α
-trifluorothymidine (FTD) and 5-chloro-6-[(2-iminopyrrolidine-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride in a molar ratio of 1;
0.5, a daily dose of 30 to 40 mg/m2/day as FTD-equivalent, divided into two to four portions for administration.
1 Assignment
Litigations
0 Petitions
Accused Products
Abstract
A method for treating cancer in patients with creatinine clearance of 15 mL/min or more and less than 30 mL/min, including dividing a combination drug containing α,α,α-trifluorothymidine (FTD) and 5-chloro-6-[(2-iminopyrrolidine-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride in a molar ratio of 1:0.5, in a dose of 30 to 50 mg/m2/day as FTD-equivalent, into two to four times a day, and orally administering it to the patient.
8 Citations
30 Claims
-
1. A method for treating cancer which is one of gastrointestinal cancer, large bowel cancer and breast cancer, comprising:
-
detecting a creatinine clearance of a patient; and orally administering to the patient with a creatinine clearance of less than 30 mL/min a combination drug comprising α
,α
,α
-trifluorothymidine (FTD) and 5-chloro-6-[(2-iminopyrrolidine-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride in a molar ratio of 1;
0.5, a daily dose of 30 to 40 mg/m2/day as FTD-equivalent, divided into two to four portions for administration. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification